tradingkey.logo

BRIEF-Alto Neuroscience Announces U.S. Patent Granted Covering Alto-300 As A Treatment For Patients With Major Depressive Disorder Characterized By An Electroencephalogram Biomarker

ReutersFeb 19, 2025 3:08 PM

- Alto Neuroscience Inc ANRO.N:

  • ALTO NEUROSCIENCE ANNOUNCES U.S. PATENT GRANTED COVERING ALTO-300 AS A TREATMENT FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER CHARACTERIZED BY AN ELECTROENCEPHALOGRAM BIOMARKER

Source text: ID:nBw56gCPna

Further company coverage: ANRO.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI